The impact of Covid-19 on cancer care has been significant. At the height of the pandemic in Europe, more than 100 million screening tests were not performed, and an estimated 1 million cancer cases went undiagnosed.
This multilingual campaign, organised by ECO’s Special Network on the Impact of Covid-19 on Cancer, raises public awareness on the pandemic’s staggering and continuing disruption of cancer care.
Find out more here.
The "Time To Act Data" Navigator tracks and highlights the disruption to cancer care caused by Covid-19 across Europe.
The tool makes it clear that:
We encourage you to use the “Time To Act” Data Navigator and to join us in our efforts. Help raise awareness of the challenges and gaps in cancer care at the European and country levels. We are united in our efforts to ensure better cancer care, restoring the confidence of European citizens and cancer patients in healthcare post-Covid-19. Together, we can make this happen!
This multilingual Toolkit comes to you with a range of materials – from infographics for social media posts to quote templates – designed to raise awareness.
The Special Network has published a landmark report combining its key recommendations: The Impact of Covid-19 on Cancer in Europe: The 7-Point Plan to Address the Urgency and Build Back Better. Compiled in consultation with the European Cancer Organisation’s community, especially members of this Network, it calls on European policymakers to take concrete actions to:
Cancer must not become the Forgotten “C” in the Fight against Covid-19
The Covid-19 pandemic has had a dramatic impact on all areas of cancer control, including prevention and vaccination, screening and early detection services, provision of all modalities of cancer treatment and care, including follow-up care for cancer survivors, and the conduct of cancer research and clinical trials. Such a challenge can only be addressed through collaboration of the entire cancer community. This led the Board of the European Cancer Organisation to launch a Special Network on the Impact of Covid-19 on Cancer, co-chaired by Board members Mirjam Crul and Mark Lawler.
The Special Network brings together a wide range of stakeholders, from our Member Societies, Patient Advisory Committee and Community 365, to: